Graybug Vision, Inc.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
      • Controlled Release
  • Biotechnology
    • Nanotechnology, Chips, etc.

Other Names/Subsidiaries

  • GrayBug, Inc.
  • GRAYBUG LLC
See more in Biomedtracker

Latest on Graybug Vision, Inc.

Scrip

CalciMedica Eyes Success In Pancreatitis, Acute Kidney Injury

 
• By Joseph Haas

CalciMedica, Inc. ’s positive top-line Phase IIb data for Auxora (CM4620) in acute pancreatitis with accompanying systemic inflammatory response syndrome (SIRS) should position the calcium release-act

Scrip

Asia Deal Watch: Rhizen Licenses Chinese Rights For PI3K Inhibitor To Curon

 
• By Ian Haydock, Vibha Ravi, Jung Won Shin, Joseph Haas, Brian Yang, and Anju Ghangurde

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Curon Picks Up China-Plus Rights to Rhi

Scrip

Finance Watch: Five More Biopharma IPOs In The US Raise $624.7m

 
• By Mandy Jackson

Initial public offerings in the US have been remarkable across industries, but the biopharmaceutical sector has dominated in terms of the number of IPOs and the performance of newly issued stocks in t

Scrip

Finance Watch: Brent Saunders Plots Return To Deal-Making With A SPAC IPO

 
• By Mandy Jackson

The question of where former Allergan plc CEO Brent Saunders would land next after the company was sold to AbbVie Inc. earlier this year for $63bn was answered in a 10 September filing with the US